Fatal dog lungworm case in Germany highlights CNS risk
Bottom line
Version 1
A new case report describes a six-year-old Labrador Retriever in Germany that died from disseminated angiostrongylosis caused by Angiostrongylus vasorum, with larvae found not only in the lungs, but also in the brain, spinal cord, kidneys, and myocardium. The report adds to a small but important body of evidence showing that A. vasorum can extend beyond its usual cardiopulmonary presentation and involve the central nervous system, leading to sudden death. Earlier German case literature has also documented fatal disseminated infections with cerebral hemorrhage, and parasitology guidance from ESCCAP notes that neurological signs and sudden death can occur, even when respiratory signs are absent. (pubmed.ncbi.nlm.nih.gov)
Why it matters: For veterinary professionals, the main takeaway is diagnostic vigilance. Canine angiostrongylosis is still easy to miss because signs can be variable, including respiratory, cardiovascular, coagulopathic, and neurologic presentations. Prior reports have shown that fecal Baermann testing may be negative in some fatal cases, while broader reviews describe coagulopathy, pulmonary hypertension, and multifocal disease as part of the syndrome. That means A. vasorum should stay on the differential list for dogs with unexplained neurologic signs, bleeding tendencies, cardiopulmonary disease, or sudden collapse, particularly in endemic or expanding-risk areas of Europe such as Germany. (pubmed.ncbi.nlm.nih.gov)
What to watch: Watch for whether this report prompts more emphasis on earlier testing, prevention, and broader differential workups for dogs with mixed respiratory-neurologic signs or unexplained sudden death. (pmc.ncbi.nlm.nih.gov)
Key facts
- Case report
- Six-year-old Labrador Retriever in Germany
- Cause
- Disseminated angiostrongylosis
- Parasite
- Angiostrongylus vasorum
- Organs with larvae
- Lungs, brain, spinal cord, kidneys, and myocardium
- Outcome
- Sudden death
- Clinical point
- The parasite can involve the central nervous system, not just the chest
- Diagnostic caution
- A negative fecal Baermann test does not reliably exclude disease in a compatible case
- Guidance note
- ESCCAP notes neurological signs and sudden death can occur, even without respiratory signs
Version 2
A newly highlighted German case report describes sudden death in a six-year-old Labrador Retriever caused by disseminated angiostrongylosis, with Angiostrongylus vasorum larvae identified across multiple organs, including the lungs, brain, spinal cord, kidneys, and myocardium. The case underscores a point small-animal clinicians have been hearing more often in recent years: this parasite doesn’t always stay in the chest, and when the central nervous system is involved, outcomes can be catastrophic. (pubmed.ncbi.nlm.nih.gov)
That matters because A. vasorum has historically been framed as a cardiopulmonary parasite, yet the clinical picture can be much broader. Reviews of canine angiostrongylosis describe respiratory disease, bleeding disorders, gastrointestinal signs, and neurologic abnormalities, with disease severity ranging from subclinical infection to fatal collapse. ESCCAP guidance also notes that sudden death can occur even without obvious respiratory signs, which helps explain why some cases may be recognized only late, or at necropsy. (pmc.ncbi.nlm.nih.gov)
Germany is not new to this problem, but the newer case fits a pattern that still appears underrecognized. A 2009 German clinical case study reported two dogs with fatal disseminated angiostrongylosis and multifocal CNS hemorrhages; both had rapidly progressive neurologic signs, elevated D-dimers, mild thrombocytopenia, and larvae identified in the brain, heart, kidney, and lung. Notably, one dog was negative on fecal Baermann examination despite confirmed infection, reinforcing that a negative fecal test does not reliably exclude disease in a compatible case. (pubmed.ncbi.nlm.nih.gov)
Broader literature supports that concern. A 2023 Frontiers report describing four lethal canine cases found evidence of severe pulmonary disease, pulmonary hypertension, thrombi, and, in some dogs, parasite presence in the neuroparenchyma. The authors argued that infection may be underestimated or misdiagnosed, especially when dogs present with nonspecific respiratory signs or are treated empirically for other conditions first. Reviews and observational studies also point to coagulation abnormalities as a major clinical issue, with one prospective study identifying bleeding diathesis in 39% of naturally infected dogs. (frontiersin.org)
Industry and guideline sources echo the same message, even if direct commentary on this specific case is limited. ESCCAP describes A. vasorum as capable of causing highly variable disease, including coagulopathy and neurologic signs, and notes that many infected dogs may initially appear clinically normal. Epidemiologic work in Germany has also suggested that the parasite’s geographic range may be expanding beyond historically recognized areas, with red foxes considered an important reservoir host. (esccap.org)
Why it matters: For veterinary teams, this case is a reminder to think beyond the classic coughing dog. In practice, A. vasorum should be part of the differential for dogs with unexplained neurologic signs, coagulopathy, pulmonary hypertension, mixed cardiopulmonary-neurologic presentations, or sudden death. It also supports a lower threshold for combining diagnostics, rather than relying on a single fecal test, when signalment, geography, imaging, clinicopathology, or history raise suspicion. Preventive counseling for pet parents in endemic-risk areas may also deserve renewed attention, especially for dogs with outdoor exposure and opportunities to ingest gastropods or other potential carriers. (pubmed.ncbi.nlm.nih.gov)
What to watch: The next step to watch is whether additional case surveillance and pathology reporting sharpen understanding of how often disseminated and neurologic angiostrongylosis is being missed, and whether that leads to stronger emphasis on screening and prevention in European practice guidance. (parasitesandvectors.biomedcentral.com)